Consistently, Barcellini et al. have highlighted the role of TLR4 and TLR9 expression in the occurrence of infections, autoimmunity, and disease progression in patients with CLL [38]. This evidence concerns the gene TLR9 and B-cell chronic lymphocytic leukemia.